A recent study by Dr. Jordan Verplank, Assistant Professor in the Department of Anatomy, Physiology, and Genetics at the ...

Much has been achieved in terms of understanding the complex clinical and genetic heterogeneity of Charcot-Marie-Tooth neuropathy (CMT). Since the identification of mutations in the first CMT ...

SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder that’s both progressive and incurable. But now, nerve specialists ...

An east Auckland teenager with a rare genetic condition is grateful for having received equipment that will make it easier ...

Mitochondria In Motion Inc. has identified new N-(trans-4-hydroxycyclohexyl)-6-phenylhexanamide derivatives acting as mitofusin activators and reported to be useful for the treatment of Alzheimer’s, ...

OBJECTIVES Charcot-Marie-Tooth disease type I (CMT1) is a hereditary sensorimotor neuropathy causing variable degrees of handicap. The risk for relevant disability in respect to genetic counselling is ...

Alan Jackson's next farewell tour concert is on Saturday, Nov. 16, 2024, in Salt Lake City, Utah. In this file photo, he ...

Sara McCready launched Gnome and Away Travel in February with her husband Kevin. Becoming a Hays Travel Explorer franchisee ...

Avicenna received a patent covering ROCK inhibitor compounds for ALS, Parkinson’s, and other neurodegenerative conditions.

The SynGAP Research Fund 501(c)(3) has awarded a pair of grants to Dr. Clement Chow, a geneticist and Associate Professor in the Department of Human Genetics at the University of Utah. These grants ...

Staff's lab is aimed at dissecting these phenomena to find preceding protein pathways that may be able to be targeted for neuroprotection. Hereditary peripheral neuropathy (Charcot-Marie-Tooth disease ...